Search results
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 6 days agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 6 days agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 5 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 6 days agoAfter topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...
Biotech’s bind over China bill
Politico· 5 days agoCEO Stéphane Bancel touted the vaccine candidate’s safety and efficacy data as “stronger” than competitors’ though another company official noted Moderna ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 6 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter revenue is down ...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 6 days agoAnd help us understand, as you've communicated with large retail pharmacy, how significant the PFS formulation is to them? A: (Stephane Bancel - CEO & Director ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 6 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID-19 vaccine.
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights
Guru Focus· 7 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Moderna Inc (MRNA, Financial) reported substantial clinical progress with exciting data on ...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 7 days agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 billion in the same ...